IRYS fluctuates 80% in 24 hours: Surges then falls back after being listed on Upbit
Bitget Pulse2026/05/16 02:47Volatility Brief
In the past 24 hours, IRYS experienced intense price fluctuations, reaching a high of $0.08985 and a low of $0.04993. It is currently trading at $0.05527, with a volatility amplitude of 80%. Stimulated by the Upbit listing news, the price once surged over 120% before profit-taking occurred, pulling back approximately 38% from the high. Trading volume surged significantly at the same time, with data from multiple platforms showing 24-hour turnover exceeded $80 million, far surpassing previous average levels. The capital flow showed a pattern of net inflow followed by partial outflow.
Brief Analysis of Abnormal Movements
- Core Driver: On May 15, 2026, Upbit announced the listing of IRYS, supporting KRW, BTC, and USDT trading pairs, with trading officially starting at 20:00 KST on the same day. This event directly triggered market FOMO sentiment and drove a significant intraday price surge.
- Trading Volume and Leverage Factors: After the listing, both spot and derivatives trading volumes spiked simultaneously, long leverage positions rapidly accumulated, and some short liquidations further amplified the volatility.
- No Other Major On-chain or Official Events: There were no large whale transfers, major contract deployments, or new team announcements observed in the past 24 hours. The price action was primarily driven by the single catalyst of the exchange listing.
Market Views and Outlook
The overall community and analyst sentiment remains optimistic, believing that the Upbit listing has significantly improved IRYS liquidity and visibility, and short-term price may maintain high volatility. Some traders note that the RSI has entered the overbought zone and warn of profit-taking risks. From a technical perspective, the $0.05 level is considered a key support area; if held, a test toward the $0.07-$0.08 range is possible. The general outlook emphasizes the need to watch whether trading volume can be sustained, otherwise further corrections may occur.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Voices of doubt arise, Moderna CEO reassures the market: Personalized cancer vaccines will cover more types of cancer
Moderna's CEO is highly confident about the prospects of the personalized mRNA cancer vaccine intismeran autogene, stating that it will play a role in more cancers beyond melanoma and drawing parallels with Merck's blockbuster drug Keytruda. Jefferies warns that cross-indication replication is still inconclusive; Citi maintains a "sell" rating, pointing out that commercial application remains limited, with critical issues such as patient suitability, manufacturing, and overall survival data yet to be addressed.
Morgan Stanley Declares U.S. Stock Market Correction Nears End! Maintains Year-End S&P 8000 Target, Identifies Three Major Rebound Catalysts
As Morgan Stanley remains bullish on the stock market, recent market trends have precisely demonstrated the strong rebound momentum of tech stocks dominated by the semiconductor sector. The Philadelphia Semiconductor Index rose by 0.44% on October 23rd and further increased by 2.82% on the 26th.
Eight Highlights of Anthropic IPO Prospectus: Astonishing Growth, but Risks are Obvious
The Anthropic prospectus reveals several highlights: a large-scale enterprise customer base with over 1,900 customers generating more than one million dollars in revenue; as of June 2026, revenue has increased by 1,368% year over year, far surpassing the growth rate of computing costs; positive operating cash flow; and all seven co-founders remain with the company. The company also acknowledges risks, including concentrated supply from TSMC and potential memory chip shortages as significant concerns. October ARR data will be additionally disclosed in a revised version of the document.
Selling Chips, Leasing, Providing Residual Value Support: Broadcom (AVGO.US) Teams Up with Wall Street's Four Giants to Raise $63 Billion to "Inject Funds" for Anthropic's Chip Procurement
Broadcom has reached a $63 billion deal with Bank of America, Blackstone Group, Citigroup, and Morgan Stanley to provide funding for the purchase of chips for AI model developer Anthropic PBC. The transaction is conducted through a newly established special purpose company, which has secured financial commitments from these firms to purchase Broadcom chips and lease them to Anthropic.
Crypto prices
More
